MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CBAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CymaBay Therapeutics (CBAY) Ownership - Who owns CymaBay Therapeutics?

CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7601 Dumbarton Circle
Phone
+1 510 293-8800
Employees
108
Web
https://www.cymabay.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.73B
P/E Ratio
N/A
Total Cash
394.26M
Projected Growth
N/A
Total Debt
114.49M
Revenue
31.07M
Risk (Beta)
-0.03
Dividend Yield
N/A
Total Cash/Share
3.43
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CBAY
A.I. Advisor
published General Information

General Information

a developer of therapeutics to treat metabolic diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
7601 Dumbarton Circle
Phone
+1 510 293-8800
Employees
108
Web
https://www.cymabay.com